Related Experiment Videos
Hibernating, stunning and ischemic preconditioning of the myocardium: therapeutic implications
1Universität Heidelberg, Germany.
Insights
Diagnosing hibernating myocardium, a state of reduced heart function due to chronic ischemia, is key for effective treatment. Understanding myocardial stunning and ischemic preconditioning offers insights into managing ischemic heart disease.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Hibernating myocardium is a compensatory mechanism for chronic ischemia from coronary stenosis.
- Accurate diagnosis of hibernating myocardium is crucial for effective treatment, primarily revascularization.
Purpose of the Study:
- To discuss the diagnostic challenges and therapeutic implications of hibernating myocardium.
- To differentiate hibernating myocardium from myocardial stunning and explore the concept of ischemic preconditioning.
Main Methods:
- Review of diagnostic methods for myocardial viability, including provocation tests and scintigraphy.
- Discussion of clinical scenarios like myocardial stunning post-revascularization and acute myocardial infarction.
- Exploration of experimental findings on ischemic preconditioning and its potential therapeutic targets.
Main Results:
- Diagnostic tests for hibernating myocardium can be limited by scar tissue.
- Myocardial stunning is a transient condition post-revascularization requiring symptomatic treatment.
- Ischemic preconditioning, while experimentally observed, lacks proven clinical significance in ischemic heart disease.
Conclusions:
- Restoration of blood flow is the primary treatment for hibernating myocardium.
- Awareness of myocardial stunning is important for post-procedural management.
- Further research into cardioprotective mechanisms like adenosine A1 receptor activation may yield future therapies.
Abstract:
Hibernating myocardium, as a compensatory mechanism to chronic ischemia caused by a tight coronary stenosis is best treated by restoration of blood flow. Hence in this condition the therapeutic implications are rather obvious and the problem is how to diagnose hibernating myocardium. Provocation tests and/or scintigraphic methods are usually used to show viability of an akinetic myocardial area. These tests, however, can be expected to be clearly positive only if hibernating myocardium is not mixed with patchy scar tissue. Physicians should be aware of myocardial stunning, when left ventricular function remains impaired immediately after revascularization, for example, after cardiac surgery of the totally ischemic organ or after thrombolytic therapy of acute myocardial infarction. Due to the self-recovery of this condition, therapeutic implications are given only when symptoms and signs of impaired ventricular function are present. Positive inotropic agents have been shown to be effective in experimental conditions and are widely accepted to be beneficial in clinical use. Based on experimental observations the term "ischemic preconditioning" has been introduced to describe a condition of increased ischemic tolerance after a short preceding period of ischemia and reperfusion. This condition, however, has never been proven to be of clinical significance in the treatment of patients with ischemic heart disease. According to some clinical observations, repeated episodes of ischemia are even associated with a worse prognosis. Therapeutic implications may arise from understanding the mechanisms involved in this cardioprotective process, for example, activation of adenosine A1 receptors.